CORE SCIENTIFIC ($CORZ) posted quarterly earnings results for Q4 2025 on Monday, March 2nd. The company reported earnings of -$0.29 per share, missing estimates of -$0.09 by $0.20. The company also reported revenue of $79,760,000, missing estimates of $124,517,724 by $-44,757,724.
You can see Quiver Quantitative's $CORZ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CORE SCIENTIFIC Insider Trading Activity
CORE SCIENTIFIC insiders have traded $CORZ stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CORZ stock by insiders over the last 6 months:
- ERIC STANTON WEISS purchased 5,000 shares for an estimated $107,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CORE SCIENTIFIC Hedge Fund Activity
We have seen 210 institutional investors add shares of CORE SCIENTIFIC stock to their portfolio, and 255 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 13,232,490 shares (+201.0%) to their portfolio in Q4 2025, for an estimated $192,665,054
- SITUATIONAL AWARENESS LP added 8,575,944 shares (+42.5%) to their portfolio in Q4 2025, for an estimated $124,865,744
- VALUE ALIGNED RESEARCH ADVISORS, LLC added 8,089,697 shares (+inf%) to their portfolio in Q4 2025, for an estimated $117,785,988
- FMR LLC removed 7,583,198 shares (-93.3%) from their portfolio in Q4 2025, for an estimated $110,411,362
- TOMS CAPITAL INVESTMENT MANAGEMENT LP removed 5,663,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $82,453,280
- VANGUARD GROUP INC added 5,359,710 shares (+18.7%) to their portfolio in Q4 2025, for an estimated $78,037,377
- COVALIS CAPITAL LLP added 5,341,913 shares (+inf%) to their portfolio in Q4 2025, for an estimated $77,778,253
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CORE SCIENTIFIC Analyst Ratings
Wall Street analysts have issued reports on $CORZ in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/06/2026
- Bernstein issued a "Outperform" rating on 11/03/2025
- Clear Street issued a "Buy" rating on 10/28/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/28/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/24/2025
- Roth Capital issued a "Buy" rating on 10/23/2025
To track analyst ratings and price targets for CORE SCIENTIFIC, check out Quiver Quantitative's $CORZ forecast page.
CORE SCIENTIFIC Price Targets
Multiple analysts have issued price targets for $CORZ recently. We have seen 9 analysts offer price targets for $CORZ in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Stephen Glagola from Keefe, Bruyette & Woods set a target price of $25.0 on 01/27/2026
- Gregory Lewis from BTIG set a target price of $23.0 on 01/06/2026
- Greg Miller from Citizens set a target price of $30.0 on 12/18/2025
- Gautam Chhugani from Bernstein set a target price of $24.0 on 11/03/2025
- Paul Golding from Macquarie set a target price of $34.0 on 10/31/2025
- Brian Dobson from Clear Street set a target price of $23.0 on 10/28/2025
- Kevin Dede from HC Wainwright & Co. set a target price of $25.0 on 10/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
